Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 1 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4UNKNOWN 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1CNS 1

Conditions

Marijuana Abuse 2Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Nausea 1Glioblastoma 1Cachexia 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × nabiximols × Clear all
NCT05629702 2026-05-05

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting
120 enrolled
CNS

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

NCT07459920 2026-03-10

CAPTURE

National Cancer Institute, Naples

Phase 2 Not yet recruiting
156 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed
91 enrolled

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

University of Copenhagen

Phase 2 Withdrawn
Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡